NANCY ABDEL-WAHAB: Open Payments
NPI 1639207350 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$65,462 in 278 payments from 14 companies in 2025. Trend: 2023 $62,267 · 2024 $51,440 · 2025 $65,462
Speaker / faculty: $48,482Consulting: $6,690Food & beverage: $6,304Travel & lodging: $3,903Education: $84
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 67 | $23,096 |
| Alkermes, Inc. | 57 | $16,740 |
| Teva Pharmaceuticals USA, Inc. | 45 | $16,184 |
| ABBVIE INC. | 28 | $7,747 |
| Axsome Therapeutics, Inc. | 23 | $535 |
| Neurocrine BioSciences, Inc. | 20 | $372 |
| Otsuka America Pharmaceutical, Inc. | 16 | $327 |
| Lundbeck LLC | 13 | $237 |
| Janssen Pharmaceuticals, Inc | 3 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
Products named: COBENFY, LYBALVI, AUSTEDO XR, VRAYLAR, UZEDY, ARISTADA, Auvelity, INGREZZA.
Industry payments across NY — which companies pay providers there.
